Table 1.
Reference | Specimen | Criteria |
---|---|---|
Mirra et al. (1976) [8] | Synovial and capsular tissues | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (500x) |
| ||
Fehring and McAlister (1994) [9] | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | Evidence of acute inflammation (no quantification) |
| ||
Feldman et al. (1995) [10] | Joint pseudocapsule and interface membrane | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Athanasou et al. (1995) [11] | Joint pseudocapsule and interface membrane | ≥1 polymorphonuclear leukocyte per HPF on average in at least 10 HPF (400x)∗ |
| ||
Lonner et al. (1996) [12] | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | ≥5 and ≥10 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Pace et al. (1997) [13] | Joint pseudocapsule and interface membrane | ≥5 polymorphonuclear leukocytes per HPF on multiple (three) HPF (600x) |
| ||
Abdul-Karim et al. (1998) [14] | Interface membrane (aseptic suspicion). Interface membrane, synovial tissue, and unusually discolored tissue (septic suspicion) | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Spangehl et al. (1999) [3] | Synovial surface | ≥5 polymorphonuclear leukocytes in any single HPF (400x) |
| ||
Pandey et al. (1999) [15] | Joint pseudocapsule and interface membrane | ≥1 polymorphonuclear leukocyte per HPF on average in at least 10 HPF (400x)∗ |
| ||
Pons et al. (1999) [2] | Synovial surface | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Della Valle et al. (1999) [16] | Joint pseudocapsule, granulation tissue, and any area that appeared suspicious for possible infection | - |
| ||
Banit et al. (2002) [17] | Joint pseudocapsule and any area that appeared suspicious for possible infection | ≥10 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Musso et al. (2003) [18] | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Malhorta and Morgan (2004) [19] | Joint pseudocapsule | ≥5 polymorphonuclear leukocytes per HPF in most areas (400x) |
| ||
Ko et al. (2005) [20] | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | ≥5 polymorphonuclear leukocytes in any single HPF (400x) |
| ||
Wong et al. (2005) [21] | Synovial surface, joint pseudocapsule, and interface membrane | ≥5 and ≥10 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Francés Borrego et al. (2006) [22] | Periprosthetic soft tissue | ≥10 polymorphonuclear leukocytes in any single HPF (400x) |
| ||
Bori et al. (2006) [23] | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Morawietz et al. (2006) [24] | Interface membrane | Evidence of acute inflammation (no quantification). Low or high grade. |
| ||
Nuñez et al. (2007) [25] | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Nilsdotter-Augustinsson et al. (2007) [26] | Synovial surface and interface membrane | ≥5 polymorphonuclear leukocytes in any single HPF (400x) |
| ||
Della Valle et al. (2007) [27] | Synovial surface | ≥10 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Bori et al. (2007) [28] | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Kanner et al. (2008) [29] | Periprosthetic soft tissue | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Müller et al. (2008) [30] | Interface membrane | Evidence of acute inflammation (no quantification) |
| ||
Schinsky et al. (2008) [31] | Synovial surface | ≥10 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Fink et al. (2008) [32] | Periprosthetic tissue | ≥5 polymorphonuclear leukocytes in any single HPF (400x) |
| ||
Schäfer et al. (2008) [33] | Periprosthetic soft tissue and membrane | ≥5 polymorphonuclear leukocytes per HPF in ≥10 HPF (400x) |
| ||
Savarino et al. (2009) [34] | - | ≥1 polymorphonuclear leukocytes in any single HPF (600x) |
| ||
Bori et al. (2009) [35] | Joint pseudocapsule, interface membrane, and any area that appeared suspicious for possible infection | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Morawietz et al. (2009) [36] | Interface membrane | ≥23 polymorphonuclear leukocytes in ≥10 HPF (400x)∗∗ |
| ||
Tohtz et al. (2010) [37] | Interface membrane | ≥2 polymorphonuclear leukocytes per HPF in at least 10 HPF (400x) |
| ||
Stroh et al. (2012) [38] | Joint pseudocapsule, synovium, and soft tissue | Mean of greater than 5 polymorphonucleocytes (PMNs) per HPF was the criteria |
| ||
Miyamae et al. (2013) [39] | Periprosthetic tissue | ≥10 polymorphonuclear leukocytes in any single HPF (400x) |
| ||
Ahmadi et al. (2013) [40] | Periprosthetic tissue | ≥5 polymorphonuclear leukocytes in any single HPF (400x) |
| ||
Muñoz-Mahamud et al. (2013) [41] | Interface membrane | ≥5 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Grosso et al. (2014) [42] | Joint pseudocapsule and interface membrane | ≥10 polymorphonuclear leukocytes per HPF in ≥5 HPF (400x) |
| ||
Buttaro et al. (2015) [43] | Joint pseudocapsule, interface membrane, and any other tissue involved according to the surgeon's judgment | ≥5 polymorphonuclear leukocytes per HPF in at least 10 HPF (400x) |
| ||
Kashima et al. (2015) [44] | Joint pseudocapsule and interface membrane | ≥2 polymorphonuclear leukocytes per HPF on average in at least 10 HPF (400x)∗∗∗ |
∗≥1 polymorphonuclear leukocyte per HPF on average after examination of at least 10 HPF; ∗∗≥23 polymorphonuclear leukocytes in ≥10 HPF (400x). In each HPF, a maximum of 10 polymorphonuclear leukocytes were counted. The sum must be between zero and 100; ∗∗∗≥2 polymorphonuclear leukocytes per HPF on average after examination of at least 10 HPF.